Loading…
Don’t miss your opportunity to be a part of this event, now a highly anticipated Campbell tradition, a decade in the making!
More information at: library.campbell.edu/symposium2020
Back To Schedule
Friday, March 27 • 08:00 - 17:00
[VIRTUAL] Nuclear Autoantigenic Sperm Protein (NASP): A Possible Diagnostic Marker for Prostate Cancer

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
This project offers an exploration of a new line of diagnostic for prostate cancer. It is based on the aberrant expression of tNASP protein in prostate cancer cells. We examined the level of anti-tNASP antibodies in the sera of patients diagnosed with prostate cancer. Combined analysis of anti-tNASP and PSA tests demonstrated that 18.18% of PC patients with PSA higher than 4 ng/mL had a low level of anti tNASP antibody (false positive PSA, supported by negative biopsy); 9.1% of PC patients with PSA lower than 4 ng/mL had high levels of anti-tNASP antibodies (false negative PSA, proved histologically).



Friday March 27, 2020 08:00 - 17:00 EDT
Online